The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease
- 31 May 2007
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 45 (5) , 936-943
- https://doi.org/10.1016/j.jvs.2007.01.024
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)Circulation, 2006
- The year in atherothrombosisJournal of the American College of Cardiology, 2004
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Statin therapy improves cardiovascular outcome of patients with peripheral artery diseasePublished by Oxford University Press (OUP) ,2004
- Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathyAmerican Journal of Physiology-Renal Physiology, 2004
- The Effect of Short-Term Treatment with Simvastatin on Renal Function in Patients with Peripheral Arterial DiseaseAngiology, 2004
- Cholesterol Reduction With Atorvastatin Improves Walking Distance in Patients With Peripheral Arterial DiseaseCirculation, 2003
- Statin Use and Leg Functioning in Patients With and Without Lower-Extremity Peripheral Arterial DiseaseCirculation, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001